| NCT ID | NCT02970045 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Southern California |
| Condition | Cancer Risk |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2016-05-02 |
| Primary Completion | 2036-05-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2016-05-02 with a primary completion date of 2036-05-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This research trial collects biological samples and clinical information to create a repository of data from patients with cancer or a predisposition for cancer. Combining genetic information from biological samples and clinical data may lead to more knowledge about why certain cancers respond to treatment and help create more personalized medicine.
Eligibility Criteria
Inclusion Criteria: * Limited to those patients who are registered for outpatient or inpatient care at University of Southern California (USC) Norris * Able to understand and sign the TCCP informed consent, California subject's bill of rights, Health Insurance Portability and Accountability Act (HIPAA), and research authorization form directly or through an authorized representative; the informed consent, subject's bill of rights, HIPAA, and research authorization will be available in both English and Spanish languages Exclusion Criteria: * Individuals who are not registered as patients for outpatient or inpatient care at USC Norris * Individuals who are unable to understand or sign the TCCP informed consent, subject's bill of rights, HIPAA, and research authorization in either English or Spanish
Contact & Investigator
Bodour Salhia, PhD
PRINCIPAL INVESTIGATOR
University of Southern California
Frequently Asked Questions
Who can join the NCT02970045 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer Risk. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02970045 currently recruiting?
Yes, NCT02970045 is actively recruiting participants. Contact the research team at Melissa.woodhouse@med.usc.edu for enrollment information.
Where is the NCT02970045 trial being conducted?
This trial is being conducted at Los Angeles, United States.
Who is sponsoring the NCT02970045 clinical trial?
NCT02970045 is sponsored by University of Southern California. The principal investigator is Bodour Salhia, PhD at University of Southern California. The trial plans to enroll 10,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.